Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Filed Chapter 11
Director departure
Appointed director
Quarterly results
K-V Pharmaceutical Co (KV.A) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2013 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/28/2012 SC 13D/A AmediusTec Ltd. reports a 4.2% stake in K-V Pharmaceutical Company
03/03/2011 SC 13D/A Centerbridge Partners, L.P. reports a 5% stake in K-V Pharmaceutical Company
06/09/2010 SC 13D/A HERMELIN MARC S reports a 7.5% stake in K-V Pharmaceutical Company
06/09/2010 SC 13D/A HERMELIN MARC S reports a 52.2% stake in K-V Pharmaceutical Company
12/15/2009 SC 13D/A KV PHARMACEUTICAL CO reports a 7.5% stake in K-V Pharmaceutical Company
12/15/2009 SC 13D/A KV PHARMACEUTICAL CO reports a 52.2% stake in K-V Pharmaceutical Company
09/02/2009 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]
09/02/2009 SC 13D/A KV PHARMACEUTICAL CO reports a 7.5% stake in K-V Pharmaceutical Company

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy